Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin analogues with improved absorption characteristics.

J Brange1, J F Hansen, L Langkjaer

  • 1Novo Research Institute, Bagsvaerd, Denmark.

Hormone and Metabolic Research. Supplement Series
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Reliability Criteria for Liver Stiffness Measurements with Real-Time 2D Shear Wave Elastography in Different Clinical Scenarios of Chronic Liver Disease.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2016
Same author

Hyperostosis corticalis generalisata. Report of seven cases.

Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen. Series C. Biological and medical sciences·2014
Same author

Validation of a turbulent Kelvin-Helmholtz shear layer model using a high-energy-density OMEGA laser experiment.

Physical review letters·2012
Same author

Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor.

Diabetes, obesity & metabolism·2010
Same author

Observation of a Kelvin-helmholtz instability in a high-energy-density plasma on the omega laser.

Physical review letters·2009
Same author

Dynamic Hohlraums as x-ray sources in high-energy density science.

The Review of scientific instruments·2008

Novel insulin analogues designed using recombinant DNA technology offer improved absorption profiles for better diabetes management. These new insulin preparations provide more physiological insulin delivery compared to current treatments.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Endocrinology

Background:

  • Current subcutaneous (s.c.) insulin injections do not mimic physiological insulin profiles.
  • There is a need for improved insulin preparations for more effective diabetes therapy.

Purpose of the Study:

  • To design novel human insulin analogues with altered physicochemical properties.
  • To modify subcutaneous absorption kinetics for improved insulin delivery.

Main Methods:

  • Utilized recombinant DNA technology to create new insulin molecules.
  • Characterized physicochemical properties and absorption kinetics of novel insulin analogues.

Main Results:

  • Long-acting insulin analogues with increased isoelectric points show slow absorption, offering stable basal delivery and reduced variation.

Related Experiment Videos

  • Rapid-acting insulin analogues with reduced self-association exhibit faster absorption, suitable for bolus injections.
  • Absorption kinetics elucidated the dose-dependent effect on insulin absorption rate.

    • Conclusions:

    • Novel insulin analogues demonstrate potential for more physiological insulin therapy.
    • Engineered insulin molecules offer improved absorption profiles for both basal and bolus delivery.
    • These advancements enhance insulin delivery, potentially improving diabetes management outcomes.